Lenacapavir treatment–emergent HIV-1 capsid resistance mutations are frequently associated with replication defects

Journal:

Science Translational Medicine

Published:

2026-01-07

DOI:

10.1126/scitranslmed.aea0947

Affiliations:

6

Authors:

13

Go to article

Institutions	Authors	Share
Gilead, United States of America (USA)	11.000000 11.000000	0.85
Yale University, United States of America (USA)	1.000000	0.08
Indiana University (IU), United States of America (USA)	1.000000	0.08

Interested in Medical Biotechnology?